Testosterone replacement therapy
Coverage of Testosterone replacement therapy in the Nexus archive.
- Judge questions difference between Hegseth's testosterone policy and transgender care for troops
A federal judge has questioned the distinction between Defense Secretary Pete Hegseth's testosterone replacement therapy (TRT) initiative for troops and hormone treatment for transgender men in the military. The inquiry occurs within a lawsuit challenging President Donald Trump's ban on transgender service members, as Judge Ana Reyes orders analysis of medical and logistical similarities between TRT for cisgender and transgender individuals.
- Judge questions difference between Hegseth's testosterone policy and transgender care for troops
A federal judge is questioning the differences between Defense Secretary Pete Hegseth's testosterone replacement therapy (TRT) policy for troops and transgender care, as part of a lawsuit challenging Trump's ban on transgender service members. Judge Ana Reyes ordered both parties to address similarities and differences in administering TRT for trans men versus cis individuals and requested information on the Pentagon's rationale for disparate treatment.
- What to know about testosterone replacement therapy as the U.S. military plans to test troops
The U.S. military plans to test troops regarding testosterone replacement therapy. Research indicates benefits for qualifying patients, but concerns persist about long-term risks and its use among men without medical need.
- Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical experts
Defense Secretary Pete Hegseth announced annual testosterone deficiency screenings for U.S. service members aged 30 and older during annual physical exams. Elective testing is available for younger service members, with testosterone replacement therapy at individual discretion. Medical experts are divided on the policy.
- ‘Sounds like gender-affirming care’: Lawmakers react to Pentagon’s testosterone treatments for troops
The Pentagon announced a program offering testosterone replacement therapy to troops over 30, prompting mixed reactions from lawmakers. Democrats criticized the initiative as resembling gender-affirming care opposed by the Trump administration, while Republicans supported it as necessary for military readiness and health.
- US Defence Secretary Hegseth announces mandatory testosterone screening for troops 30 years old or above
US Defence Secretary Pete Hegseth announced mandatory annual testosterone screening for troops aged 30 or older to address testosterone deficiency, with voluntary hormone replacement therapy available for those diagnosed. The policy faces criticism from Democrats, who contrast it with Hegseth's prior ban on transgender service members requiring hormone therapy.
- Trump defence chief Hegseth unveils plan to test US troops for low testosterone
US Defence Secretary Pete Hegseth announced a new annual screening programme for testosterone deficiency among troops aged 30 and older, with voluntary testing available for those under 30. The initiative aims to ensure troops operate at their 'absolute best' through testosterone replacement therapy if needed.
- Hegseth announces new policy to test troops for low testosterone
Defense Secretary Pete Hegseth announced annual testosterone deficiency screenings for troops aged 30 and older, with younger troops able to volunteer. The policy aims to maintain troop strength and readiness but lacks specific targeted conditions or research backing. It aligns with broader Trump administration efforts to ease testosterone replacement therapy access.
- Hegseth announces annual testosterone screenings for service members
Defense Secretary Pete Hegseth announced annual testosterone screenings for service members aged 30 and older, including access to testosterone replacement therapy, as part of periodic health assessments aimed at maintaining military lethality.
- Scientists say GLP-1s improved male testosterone levels and sperm count
GLP-1 medications improved testosterone levels, sperm count, and sperm morphology in men after 24 weeks, according to a study led by Dr. Pratibha Natesh. However, experts caution more research is needed before prescribing these drugs for male infertility, noting potential risks from sudden weight loss and metabolic changes.
- Testosterone is being overprescribed to men — here's who should take it, and when it backfires
Testosterone therapy is overprescribed in the US, with 88% of men in a study not meeting criteria for treatment, risking heart issues, infertility, and long-term dependence. The University of Michigan study highlights improper prescriptions to men with conditions like sleep apnea or prostate cancer, as TRT use has quadrupled since the 1990s.
- Daily briefing: Who needs testosterone therapy?
The article discusses testosterone replacement therapy and its benefits and risks for men and women, while also mentioning US lawmakers' rejection of Trump's budget cuts and featuring scientists from Iran. Testosterone therapy is a topic of interest in the medical field. The article covers various topics including science and politics.